BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 32390415)

  • 21. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
    Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
    Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralization of pH-Sensitive Doxorubicin Prodrug in ZIF-8 to Enable Targeted Delivery to Solid Tumors.
    Yan J; Liu C; Wu Q; Zhou J; Xu X; Zhang L; Wang D; Yang F; Zhang H
    Anal Chem; 2020 Aug; 92(16):11453-11461. PubMed ID: 32664723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
    Xu W; Lou Y; Chen W; Kang Y
    Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
    Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
    Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple method for fabrication of metal-organic framework within a carboxymethylcellulose/graphene quantum dots matrix as a carrier for anticancer drug.
    Pooresmaeil M; Namazi H; Salehi R
    Int J Biol Macromol; 2020 Dec; 164():2301-2311. PubMed ID: 32805288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin.
    Li M; Yue X; Wang Y; Zhang J; Kan L; Jing Z
    J Mater Chem B; 2019 Dec; 7(47):7619-7626. PubMed ID: 31746936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Black Phosphorus Quantum Dots Gated, Carbon-Coated Fe
    Zhang M; Wang W; Wu F; Graveran K; Zhang J; Wu C
    Chemistry; 2018 Sep; 24(49):12890-12901. PubMed ID: 29855103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular imprinted S-nitrosothiols nanoparticles for nitric oxide control release as cancer target chemotherapy.
    Liu T; Qiao Z; Wang J; Zhang P; Zhang Z; Guo DS; Yang X
    Colloids Surf B Biointerfaces; 2019 Jan; 173():356-365. PubMed ID: 30316082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
    Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH/redox dual-responsive amphiphilic zwitterionic polymers with a precisely controlled structure as anti-cancer drug carriers.
    Wu Z; Gan Z; Chen B; Chen F; Cao J; Luo X
    Biomater Sci; 2019 Aug; 7(8):3190-3203. PubMed ID: 31145392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
    Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Block copolymer@ZIF-8 nanocomposites as a pH-responsive multi-steps release system for controlled drug delivery.
    Lei Z; Tang Q; Ju Y; Lin Y; Bai X; Luo H; Tong Z
    J Biomater Sci Polym Ed; 2020 Apr; 31(6):695-711. PubMed ID: 31914358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
    Zhang Y; Wei C; Lv F; Liu T
    Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
    Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
    ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects.
    Ye DX; Ma YY; Zhao W; Cao HM; Kong JL; Xiong HM; Möhwald H
    ACS Nano; 2016 Apr; 10(4):4294-300. PubMed ID: 27018822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.